Sterlization Device Essure Stays On While Bayer Studies Risks
The U.S. Food and Drug Administration allowed Bayer AG to continue marketing its controversial permanent birth control device Essure amid thousands of reports of serious health problems linked to the device,...To view the full article, register now.
Already a subscriber? Click here to view full article